Modular Medical, Inc. (MODD) Dividend History

Modular Medical, Inc. (MODD) is a medical device company focused on developing and commercializing innovative solutions for the management of diabetes. The company's flagship product is a wearable insulin management system designed to improve the quality of life for individuals with diabetes by providing precise, automated insulin delivery. Modular Medical aims to simplify diabetes care through advanced automation and user-friendly design.

16772 West Bernardo Drive, San Diego, CA, 92127
Phone: 858-800-3500
Website:

Dividend History

Modular Medical, Inc. currently does not pay dividends

Company News

  • The AI-IoT chipset market is expected to grow rapidly, driven by advancements in AI-driven data analytics, digital twins, and blockchain integration. The market is segmented by end-use applications and technologies, with opportunities across consumer electronics, automotive, healthcare, and industrial sectors.

    GlobeNewswire Inc.
    Featured Companies: AMD GOOG GOOGL IBM
  • Modular Medical's (MODD) latest U.S. patent is likely to protect the company's technology addressing pairing and allow clinicians to easily upload and review patients' data.

    Zacks Investment Research
    Featured Companies: DVA ITGR MMSI
  • Modular Medical, Inc. (MODD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

    Zacks Investment Research
  • Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) gained 53.1% to $0.3264 after the company received an Innovation Technology contract from Vizient for its novel AI-driven precision heart disease tests. Verve Therapeutics, Inc. (NASDAQ: VERV) jumped 27% to $11.95. Eli Lilly said it will acquire rights under Beam Therapeutics’ amended collaboration and license agreement with Verve, including rights to co-develop and co-commercialize Verve's base editing programs for cardiovascular disease. BioVie Inc. (NASDAQ: BIVI) rose 23.6% to $4.7840. Wolfspeed, Inc. (NYSE: WOLF) jumped 22.7% to $34.02 after the company reported first-quarter earnings. Repligen Corporation (NASDAQ: RGEN) gained 20.5% to $137.65 following better-than-expected results. Mullen Automotive, Inc. (NASDAQ: MULN) rose 20.1% to $0.3051. YanGuFang International Group Co., Ltd. (NASDAQ: YGF) gained 19.5% to $2.81. Shutterstock, Inc. (NYSE: SSTK) climbed 18.6% to $40.71 after the company posted upbeat third-quarter results and raised FY23 outlook. Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) rose 17.7% to $23.21 following third-quarter results. Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares gained 17.5% to $0.1090 after the company announced it has completed the divestiture of AVTX-800 Series. Pinterest, Inc. (NYSE: PINS) shares rose 16.9% to $29.34 after the company reported better-than-expected third-quarter financial results and issued guidance. Two Harbors Investment Corp. (NYSE: TWO) climbed 16.8% to $11.74 following quarterly results. Conduit Pharmaceuticals Inc. (NASDAQ: CDT) rose 16.5% to $1.83. Femasys Inc. (NASDAQ: FEMY) gained 16.5% to $1.62. Modular Medical, Inc. (NASDAQ: MODD) jumped 15% to $1.23. Evaxion Biotech A/S (NASDAQ: EVAX) climbed 14.8% to $1.09. Insperity, Inc. (NYSE: NSP) gained 14.3% to $110.31 following upbeat results. EUDA Health Holdings Limited (NASDAQ: ...

    Benzinga
  • The Dow Jones closed lower by over 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Tecogen The Trade: Tecogen Inc. (OTC: TGEN) Director Earl R Lewis acquired a total of 25,000 shares an average price of $0.91. To acquire these shares, it cost ...

    Benzinga
Dividend data last updated 06/06/2025 23:58:05 UTC